The skin as a diagnostic and regulatory organ of water balance in septic and cardiogenic shock - SkInShock

niversitätsmedizin der Johannes Gutenberg-Universität Mainz - Zentrum für Kardiologie Kardiologie I0 sites60 target enrollmentJanuary 28, 2022

Overview

Phase: 未知
Intervention: Not specified
Conditions: R57.0
Sponsor: niversitätsmedizin der Johannes Gutenberg-Universität Mainz - Zentrum für Kardiologie Kardiologie I
Enrollment: 60
Status: Not yet recruiting
Last Updated: last year

No summary available.

Registry

who.int

Start Date

January 28, 2022

End Date

TBD

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

niversitätsmedizin der Johannes Gutenberg-Universität Mainz - Zentrum für Kardiologie Kardiologie I

•All patients with septic or cardiogenic shock who are admitted to our ward and do not meet exclusion criteria will be included in the study and randomised upon admission to the ICU.
•Since patients in septic or cardiogenic shock in the acute phase of the disease are mostly intubated and sedated, all information will be provided to them as soon as possible. Informed informed consent is obtained only if an informed consent interview is reasonable in the individual case, or a legal guardian/proxy has been appointed who can give consent for the patient. As no additional invasive measures are carried out in the context of the study and the
•and the apparative diagnostics used consist exclusively of measurements with medical devices within the scope of their approval, subsequent inclusion is possible.

•Cutaneous infection focus, burns, pregnant women.
•Initially, all patients with cardiogenic or septic shock are included who do not meet the above exclusion criteria.
•The written consent of the patient will be obtained when the patient has passed the acute phase of the disease and is has regained full capacity to consent or a legal guardian has been appointed.